Cargando…

Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor

PURPOSE: To evaluate the rate of pyuria and bacteriuria after transurethral resection of bladder tumor (TURBT). MATERIALS AND METHODS: We retrospectively evaluated data obtained from 363 patients who underwent TURBT between October 2012 and December 2013 at Seoul National University Hospital. Urinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Byung Soo, Tae, Bum Sik, Ku, Ja Hyeon, Kwak, Cheol, Kim, Hyeon Hoe, Jeong, Chang Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754576/ https://www.ncbi.nlm.nih.gov/pubmed/29333509 http://dx.doi.org/10.4111/icu.2018.59.1.10

Ejemplares similares

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
por: Tae, Bum Sik, et al.
Publicado: (2017)

Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor
por: Kang, Minyong, et al.
Publicado: (2016)

Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

Does reduced E-cadherin expression correlate with poor prognosis in patients with upper tract urothelial cell carcinoma?: A systematic review and meta-analysis
por: Tae, Bum Sik, et al.
Publicado: (2019)

Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
por: Kim, Hyung Suk, et al.
Publicado: (2016)

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Tae, Bum Sik, et al.
Publicado: (2017)

RE: Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Impact of Squamous and Glandular Differentiation on Oncologic Outcomes in Upper and Lower Tract Urothelial Carcinoma
por: Lee, Young Ju, et al.
Publicado: (2014)

Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis
por: Kim, Min Hyuk, et al.
Publicado: (2021)

Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors
por: Lee, Kyeongchae, et al.
Publicado: (2022)

Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database Study
por: Seo, Gi Hyeon, et al.
Publicado: (2016)

Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro
por: Kang, Minyong, et al.
Publicado: (2014)

Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis
por: Ko, Kyungtae, et al.
Publicado: (2017)

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-Analysis
por: Jeon, Chanhoo, et al.
Publicado: (2013)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs
por: Kang, Minyong, et al.
Publicado: (2016)

Prognostic Significance of Lymphovascular Invasion in Radical Cystectomy on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis
por: Kim, Hwanik, et al.
Publicado: (2014)

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Non-invasive Parameters Predicting Bladder Outlet Obstruction in Korean Men with Lower Urinary Tract Symptoms
por: Kang, Min-Yong, et al.
Publicado: (2010)

Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Kwon, Dae Hyeon, et al.
Publicado: (2012)

High-Dose Terazosin Therapy (5 mg) in Korean Patients with Lower Urinary Tract Symptoms with or without Concomitant Hypertension: A Prospective, Open-Label Study
por: Kwak, Cheol, et al.
Publicado: (2007)

Comparison of intraoperative handling and wound healing between (NEOSORB® plus) and coated polyglactin 910 suture (NEOSORB®): a prospective, single-blind, randomized controlled trial
por: Tae, Bum Sik, et al.
Publicado: (2018)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials
por: Quan, Yongjun, et al.
Publicado: (2017)

Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients
por: Kim, Hyung Suk, et al.
Publicado: (2015)

The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy
por: Lee, Joong Sub, et al.
Publicado: (2015)

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Conditional Survival and Associated Prognostic Factors in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Retrospective Study at a Single Institution
por: Kang, Minyong, et al.
Publicado: (2016)

Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National university hospital experience
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells
por: Lee, Kyoung-Hwa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a0lp9v2bu3uct3vl072489e0hk